{"title":"可能用于治疗 COVID-19 的药剂：利福平","authors":"Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun","doi":"10.5501/wjv.v11.i5.391","DOIUrl":null,"url":null,"abstract":"<p><p>Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent <i>in silico</i> studies. <i>In silico</i> studies can serve as a foundation for further studies.</p>","PeriodicalId":61903,"journal":{"name":"世界病毒学杂志(英文版)","volume":"11 5","pages":"391-393"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/3f/WJV-11-391.PMC9523331.pdf","citationCount":"0","resultStr":"{\"title\":\"Possible agent for COVID-19 treatment: Rifampicin.\",\"authors\":\"Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun\",\"doi\":\"10.5501/wjv.v11.i5.391\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent <i>in silico</i> studies. <i>In silico</i> studies can serve as a foundation for further studies.</p>\",\"PeriodicalId\":61903,\"journal\":{\"name\":\"世界病毒学杂志(英文版)\",\"volume\":\"11 5\",\"pages\":\"391-393\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/3f/WJV-11-391.PMC9523331.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"世界病毒学杂志(英文版)\",\"FirstCategoryId\":\"1089\",\"ListUrlMain\":\"https://doi.org/10.5501/wjv.v11.i5.391\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"世界病毒学杂志(英文版)","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.5501/wjv.v11.i5.391","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Possible agent for COVID-19 treatment: Rifampicin.
Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent in silico studies. In silico studies can serve as a foundation for further studies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
